Publicaties WCN-studies: dr. G.C.M. Linssen

• Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fractionEuropean Heart Journal - Linssen, dr. G.C.M. - PARAGON - Heart failure July 2021
• Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialCirc Heart Fail - Abstract - Linssen, dr. G.C.M. - PARAGON - Heart failure November 2019
• Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart FailureCirculation - Abstract - Linssen, dr. G.C.M. - PARAGON; PARADIGM-2314 - Heart failure November 2019
• Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.Circ Heart Fail. - Abstract - Linssen, dr. G.C.M. - PARAGON - Heart failure July 2018
• Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndromeAm Heart J - Abstract - Hof, prof. dr. A.W. J. van 't; Alings, dr. A.M.W.; Lok, dr. D.J.A.; Liem, dr. A.H.; Kragten, dr. J.A.; Bronzwaer, drs. P.N.A. [inactief]; Cornel, prof. dr. J.H.; Freericks, M.P.; Hamer, drs. B.J.B.; Hamraoui, drs. K.; Hoedemaker, drs. G. [inactief]; Kuijper, dr. A.F.M.; Linssen, dr. G.C.M.; Louwerenburg, drs. J.W. [inactief]; Nierop, drs. P.R.; Oomen, drs. A. [inactief]; Plomp, drs. J.; Pos, drs. L.; Eck, dr. J.W.M. van; Willems, dr. F.F. - Dal-OUTCOMES - ASCVD December 2009